nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—F2—hepatic artery—duodenum cancer	0.196	0.254	CbGeAlD
Suramin—F2—portal vein—duodenum cancer	0.171	0.221	CbGeAlD
Suramin—P2RY2—endocrine gland—duodenum cancer	0.0352	0.0456	CbGeAlD
Suramin—FSHR—endocrine gland—duodenum cancer	0.0331	0.0428	CbGeAlD
Suramin—F2—gall bladder—duodenum cancer	0.0293	0.0379	CbGeAlD
Suramin—SIRT1—pancreas—duodenum cancer	0.0256	0.0331	CbGeAlD
Suramin—FSHR—G alpha (s) signalling events—SCT—duodenum cancer	0.0248	0.109	CbGpPWpGaD
Suramin—SIRT1—digestive system—duodenum cancer	0.0218	0.0282	CbGeAlD
Suramin—SIRT5—endocrine gland—duodenum cancer	0.0218	0.0281	CbGeAlD
Suramin—ARSA—digestive system—duodenum cancer	0.0216	0.0279	CbGeAlD
Suramin—P2RX4—endocrine gland—duodenum cancer	0.0206	0.0266	CbGeAlD
Suramin—P2RY2—G alpha (q) signalling events—GAST—duodenum cancer	0.0195	0.0858	CbGpPWpGaD
Suramin—SIRT1—endocrine gland—duodenum cancer	0.018	0.0233	CbGeAlD
Suramin—PLA2G2A—pancreas—duodenum cancer	0.0179	0.0231	CbGeAlD
Suramin—ARSA—endocrine gland—duodenum cancer	0.0178	0.023	CbGeAlD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.0174	0.0767	CbGpPWpGaD
Suramin—RYR1—endocrine gland—duodenum cancer	0.0167	0.0216	CbGeAlD
Suramin—PLA2G2A—digestive system—duodenum cancer	0.0153	0.0198	CbGeAlD
Suramin—SIRT5—lymph node—duodenum cancer	0.015	0.0195	CbGeAlD
Suramin—P2RX4—lymph node—duodenum cancer	0.0142	0.0184	CbGeAlD
Suramin—PLA2G2A—endocrine gland—duodenum cancer	0.0126	0.0163	CbGeAlD
Suramin—SIRT1—lymph node—duodenum cancer	0.0125	0.0161	CbGeAlD
Suramin—ARSA—lymph node—duodenum cancer	0.0123	0.0159	CbGeAlD
Suramin—F2—digestive system—duodenum cancer	0.0115	0.0149	CbGeAlD
Suramin—F2—endocrine gland—duodenum cancer	0.00953	0.0123	CbGeAlD
Suramin—P2RY2—GPCR ligand binding—SCT—duodenum cancer	0.0093	0.041	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—SCT—duodenum cancer	0.00899	0.0396	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00883	0.0389	CbGpPWpGaD
Suramin—PLA2G4A—endocrine gland—duodenum cancer	0.00878	0.0114	CbGeAlD
Suramin—PLA2G2A—lymph node—duodenum cancer	0.00873	0.0113	CbGeAlD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00853	0.0376	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—SST—duodenum cancer	0.00673	0.0296	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—SST—duodenum cancer	0.0065	0.0286	CbGpPWpGaD
Suramin—PLA2G4A—lymph node—duodenum cancer	0.00607	0.00785	CbGeAlD
Suramin—F2—G alpha (q) signalling events—GAST—duodenum cancer	0.00556	0.0245	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—GAST—duodenum cancer	0.00555	0.0244	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—GAST—duodenum cancer	0.00536	0.0236	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—SCT—duodenum cancer	0.00526	0.0232	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—SCT—duodenum cancer	0.00508	0.0224	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—GAST—duodenum cancer	0.00504	0.0222	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.00497	0.0219	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—GAST—duodenum cancer	0.00486	0.0214	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—SCT—duodenum cancer	0.00478	0.021	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—SCT—duodenum cancer	0.00461	0.0203	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—SST—duodenum cancer	0.0038	0.0168	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—SST—duodenum cancer	0.00376	0.0166	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—SST—duodenum cancer	0.00367	0.0162	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—SST—duodenum cancer	0.00345	0.0152	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—SST—duodenum cancer	0.00333	0.0147	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—GAST—duodenum cancer	0.00298	0.0131	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—MEN1—duodenum cancer	0.00293	0.0129	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—GAST—duodenum cancer	0.00287	0.0127	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—SCT—duodenum cancer	0.00282	0.0124	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—SCT—duodenum cancer	0.00272	0.012	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—SCT—duodenum cancer	0.00266	0.0117	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00252	0.0111	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MEN1—duodenum cancer	0.00247	0.0109	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MEN1—duodenum cancer	0.00238	0.0105	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—SST—duodenum cancer	0.00204	0.00899	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—SST—duodenum cancer	0.00197	0.00868	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—SST—duodenum cancer	0.00192	0.00847	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—GAST—duodenum cancer	0.00159	0.00698	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—SCT—duodenum cancer	0.0015	0.00662	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—GAST—duodenum cancer	0.00144	0.00634	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—SCT—duodenum cancer	0.00136	0.00601	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—GAST—duodenum cancer	0.00132	0.0058	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—SCT—duodenum cancer	0.00125	0.0055	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—SST—duodenum cancer	0.00109	0.00479	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—SST—duodenum cancer	0.000987	0.00435	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—SST—duodenum cancer	0.000902	0.00398	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GAST—duodenum cancer	0.00085	0.00375	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SCT—duodenum cancer	0.000806	0.00355	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GAST—duodenum cancer	0.000778	0.00343	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SCT—duodenum cancer	0.000737	0.00325	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MEN1—duodenum cancer	0.000705	0.0031	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MEN1—duodenum cancer	0.000644	0.00284	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SST—duodenum cancer	0.000583	0.00257	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SST—duodenum cancer	0.000533	0.00235	CbGpPWpGaD
